PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsliver cirrhosis
MeSH D008103 - liver cirrhosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D005355:Fibrosis
0 Companies
0 Drugs
Success rate
D008107:Liver diseases
2 Companies
2 Drugs
$
Success rate
D008103: 
Liver cirrhosis
95 Companies
20 Drugs
$
Success rate
D008104:Alcoholic liver cirrhosis
0 Companies
0 Drugs
Success rate
D008105:Biliary liver cirrhosis
37 Companies
5 Drugs
$
Success rate
D008106:Experimental liver cirrhosis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
MylanFurosemide Furosemide  1986-10-29   
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
57%
20/35
Phase 2
60%
50/84
Phase 3
43%
42/97
Approved: 10Overall Success rate: 15%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Roche
Vitamin k,
Aspartame,
Bevifimod,
Retinol,
Fendrix
Boehringer Ingelheim
Clonidine,
Faldaprevir,
Sodium chloride,
Bevifimod,
CILUPREVIR,
Sglt2,
Antacid,
Betaloc
AbbVie
Corticorelin,
Nepidermin,
Mk0518,
Arm1,
Arm2
AstraZeneca
Furosemide,
Zibotentan,
AZD2389,
Sglt2,
Farxiga
Novartis
Chlorthalidone,
Cenicriviroc,
Benzocaine,
Serelaxin,
Adefovir,
Alpha1-proteinase inhibitor,
LICOGLIFLOZIN,
TROPIFEXOR,
Fendrix,
Enecavir,
Sglt2,
Solumedrol
Sanofi
Furosemide,
Satavaptan,
Insulin,
Viaject
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use